Lehmann, Jörgen, 1898-1989
URI(s)
Fuller Name
Identifies LC/NAF RWO
Identifies RWO
Exact Matching Concepts from Other Schemes
Closely Matching Concepts from Other Schemes
Sources
found: Svenska läkartidningen, 43:e årg., nr 33, 1946:page 2029 (Kemoterapi av tuberkulos, av Jörgen Lehmann)
found: Wikipedia (English), August 26, 2015(Jörgen Erik Lehmann (15 January 1898-26 December 1989) was a Danish-born Swedish physician and chemist best known for his discovery in the 1940s that para-amino salicylic acid (PAS) would make an excellent orally-available tuberculosis therapy. PAS was, together with streptomycin, the first efficacious anti-microbial therapy for tuberculosis and remained in clinical use for several decades. Lehmann studied under Torsten Thunberg, professor of physiology in Lund, who discovered the dehydrogenases. Lehmann was appointed professor of physiology in Aarhus in 1937, and became head of the central laboratory at the Sahlgrenska University Hospital in Gothenburg 1938. After retiring in 1963, Lehmann continued his research at the Nobel Laureate Arvid Carlsson's institution at the University of Gothenburg)
Instance Of
Scheme Membership(s)
Collection Membership(s)
Change Notes
2015-09-08: new
2015-09-15: revised
Alternate Formats